These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 12039110)

  • 1. Estradiol absorption from vaginal tablets in postmenopausal women.
    Notelovitz M; Funk S; Nanavati N; Mazzeo M
    Obstet Gynecol; 2002 Apr; 99(4):556-62. PubMed ID: 12039110
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
    Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17beta-estradiol vaginal tablet versus conjugated equine estrogen vaginal cream to relieve menopausal atrophic vaginitis.
    Rioux JE; Devlin C; Gelfand MM; Steinberg WM; Hepburn DS
    Menopause; 2000; 7(3):156-61. PubMed ID: 10810960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose 17 beta-estradiol vaginal tablets in the treatment of atrophic vaginitis: a double-blind placebo controlled study.
    Eriksen PS; Rasmussen H
    Eur J Obstet Gynecol Reprod Biol; 1992 Apr; 44(2):137-44. PubMed ID: 1587379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-dose 17-β-estradiol cream for vaginal atrophy in a cohort without prolapse: Serum levels and vaginal response including tissue biomarkers associated with tissue remodeling.
    Illston JD; Wheeler TL; Parker CR; Conner MG; Burgio KL; Goode PS; Richter HE
    Maturitas; 2015 Aug; 81(4):475-9. PubMed ID: 26115591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of urogenital atrophy with low-dose estradiol: preliminary results.
    Santen RJ; Pinkerton JV; Conaway M; Ropka M; Wisniewski L; Demers L; Klein KO
    Menopause; 2002; 9(3):179-87. PubMed ID: 11973441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
    Schug BS; Donath F; Blume HH
    Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Minimized estradiol absorption with ultra-low-dose 10 microg 17beta-estradiol vaginal tablets.
    Eugster-Hausmann M; Waitzinger J; Lehnick D
    Climacteric; 2010 Jun; 13(3):219-27. PubMed ID: 20423242
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
    Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
    Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, double-blind, placebo-controlled phase 2 pilot trial evaluating a novel, vaginal softgel capsule containing solubilized estradiol.
    Pickar JH; Amadio JM; Hill JM; Bernick BA; Mirkin S
    Menopause; 2016 May; 23(5):506-10. PubMed ID: 26836245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Safety of promestriene capsule used in postmenopausal atrophic vaginitis].
    Sun AJ; Lin SQ; Jing LH; Wang ZY; Ye JL; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2009 Aug; 44(8):593-6. PubMed ID: 20003787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic estradiol levels with low-dose vaginal estrogens.
    Santen RJ; Mirkin S; Bernick B; Constantine GD
    Menopause; 2020 Mar; 27(3):361-370. PubMed ID: 31794498
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The comparison of hyaluronic acid vaginal tablets with estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
    Ekin M; Yaşar L; Savan K; Temur M; Uhri M; Gencer I; Kıvanç E
    Arch Gynecol Obstet; 2011 Mar; 283(3):539-43. PubMed ID: 20135132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultra-low-dose estriol and Lactobacillus acidophilus vaginal tablets (Gynoflor(®)) for vaginal atrophy in postmenopausal breast cancer patients on aromatase inhibitors: pharmacokinetic, safety, and efficacy phase I clinical study.
    Donders G; Neven P; Moegele M; Lintermans A; Bellen G; Prasauskas V; Grob P; Ortmann O; Buchholz S
    Breast Cancer Res Treat; 2014 Jun; 145(2):371-9. PubMed ID: 24718774
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TX-004HR vaginal estradiol has negligible to very low systemic absorption of estradiol.
    Archer DF; Constantine GD; Simon JA; Kushner H; Mayer P; Bernick B; Graham S; Mirkin S;
    Menopause; 2017 May; 24(5):510-516. PubMed ID: 28002201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local oestrogen for vaginal atrophy in postmenopausal women.
    Suckling J; Lethaby A; Kennedy R
    Cochrane Database Syst Rev; 2003; (4):CD001500. PubMed ID: 14583935
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Local estrogen replacement therapy in postmenopausal atrophic vaginitis: efficacy and safety of low dose 17beta-estradiol vaginal tablets.
    Mainini G; Scaffa C; Rotondi M; Messalli EM; Quirino L; Ragucci A
    Clin Exp Obstet Gynecol; 2005; 32(2):111-3. PubMed ID: 16108394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of 17beta-estradiol-regulated genes in the vagina of postmenopausal women with vaginal atrophy.
    Cotreau MM; Chennathukuzhi VM; Harris HA; Han L; Dorner AJ; Apseloff G; Varadarajan U; Hatstat E; Zakaria M; Strahs AL; Crabtree JS; Winneker RC; Jelinsky SA
    Maturitas; 2007 Dec; 58(4):366-76. PubMed ID: 17997058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of vaginal estriol and progesterone in postmenopausal women with atrophic vaginitis.
    Chollet JA; Carter G; Meyn LA; Mermelstein F; Balk JL
    Menopause; 2009; 16(5):978-83. PubMed ID: 19390463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Action of 25 microg 17beta-oestradiol vaginal tablets in the treatment of vaginal atrophy in Greek postmenopausal women; clinical study.
    Akrivis Ch; Varras M; Thodos A; Hadjopoulos G; Bellou A; Antoniou N
    Clin Exp Obstet Gynecol; 2003; 30(4):229-34. PubMed ID: 14664420
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.